Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
PPAR Research
|
January 30, 2007
A forum for a highly important and ever-expanding field of study
Mostafa Badr
Journal of the American Dental Association (1939)
|
November 2, 2010
Chronic kidney disease: pharmacological considerations for the dentist
William Brockmann, Mostafa Badr
Thescientificworldjournal
|
June 14, 2003
Enhanced hepatocarcinogenicity due to agonists of peroxisome proliferator-activated receptors in senescent rats: role of peroxisome proliferation, cell proliferation, and apoptosis
Jihan Youssef, Mostafa Badr
Journal of Biomedicine & Biotechnology
|
August 5, 2004
Role of Peroxisome Proliferator-Activated Receptors in Inflammation Control
Jihan Youssef, Mostafa Badr
British Journal of Pharmacology
|
April 1, 2011
Peroxisome proliferator-activated receptors and cancer: challenges and opportunities
Jihan Youssef, Mostafa Badr
PPAR Research
|
July 29, 2009
PPARs in Viral Disease
Jacqueline Capeau, Lawrence Serfaty, Mostafa Badr
PPAR Research
|
December 18, 2009
Genetic Variation of PPARs
Marie-Claude Vohl, Mostafa Badr, Stefan Wieczorek
Journal of Clinical Medicine
|
February 13, 2025
Stable Yet Destabilised: Towards Understanding Brain Network Dynamics in Psychogenic Disorders
Mostafa Badr, Timo Bröhl, Nayrin Dissouky, et al.
Epilepsia
|
April 28, 2025
Do cognitive activities during neuropsychological testing trigger seizures?
Sophia Wismeth, Mostafa Badr, Christoph Helmstaedter, et al.
Mechanisms of Ageing and Development
|
November 12, 2002
Senescence-associated decline in hepatic peroxisomal enzyme activities corresponds with diminished levels of retinoid X receptor alpha, but not peroxisome proliferator-activated receptor alpha
Christine Chao, Jihan Youssef, Mohammad Rezaiekhaleigh, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
PPAR Research
|
January 30, 2007
A forum for a highly important and ever-expanding field of study
Mostafa Badr
Journal of the American Dental Association (1939)
|
November 2, 2010
Chronic kidney disease: pharmacological considerations for the dentist
William Brockmann, Mostafa Badr
Thescientificworldjournal
|
June 14, 2003
Enhanced hepatocarcinogenicity due to agonists of peroxisome proliferator-activated receptors in senescent rats: role of peroxisome proliferation, cell proliferation, and apoptosis
Jihan Youssef, Mostafa Badr
Journal of Biomedicine & Biotechnology
|
August 5, 2004
Role of Peroxisome Proliferator-Activated Receptors in Inflammation Control
Jihan Youssef, Mostafa Badr
British Journal of Pharmacology
|
April 1, 2011
Peroxisome proliferator-activated receptors and cancer: challenges and opportunities
Jihan Youssef, Mostafa Badr
PPAR Research
|
July 29, 2009
PPARs in Viral Disease
Jacqueline Capeau, Lawrence Serfaty, Mostafa Badr
PPAR Research
|
December 18, 2009
Genetic Variation of PPARs
Marie-Claude Vohl, Mostafa Badr, Stefan Wieczorek
Journal of Clinical Medicine
|
February 13, 2025
Stable Yet Destabilised: Towards Understanding Brain Network Dynamics in Psychogenic Disorders
Mostafa Badr, Timo Bröhl, Nayrin Dissouky, et al.
Epilepsia
|
April 28, 2025
Do cognitive activities during neuropsychological testing trigger seizures?
Sophia Wismeth, Mostafa Badr, Christoph Helmstaedter, et al.
Mechanisms of Ageing and Development
|
November 12, 2002
Senescence-associated decline in hepatic peroxisomal enzyme activities corresponds with diminished levels of retinoid X receptor alpha, but not peroxisome proliferator-activated receptor alpha
Christine Chao, Jihan Youssef, Mohammad Rezaiekhaleigh, et al.
Page
of 3